The FDA identified the recall of LeMaitre Vascular (NSDQ:LMAT) Over the Wire embolectomy catheters for a failure to deflate as a Class I recall. Burlington, Mass.–based LeMaitre Vascular’s Over the Wire embolectomy catheter is indicated for use in the surgical removal of blood clots that are lodged in a blood vessel (emboli) and blood clots that form […]
LeMaitre Vascular (NSDQ:LMAT) shares plummetted today on fourth-quarter results that came up shy of the consensus forecast and revealed a big dip in profits. The Burlington, Mass.–based maker of peripheral vascular disease devices posted profits of $4.6 million, or 23¢ per share, on sales of $30.2 million for the three months ended Dec. 31, 2019, for […]
Admedus (ASX:AHZ) dealt its biologic patch business to LeMaitre Vascular (NSDQ:LMAT) in a deal worth up to $24.6 million to focus on the transcatheter aortic valve replacement market. The A$36.2 million buyout of the CardioCel and VascuCel patches called for LeMaitre to put up $14.2 million up front, with another $1.4 million due in a pair […]
LeMaitre Vascular (NSDQ:LMAT) said today it inked a deal to acquire Becton Dickinson‘s (NYSE:BDX) Cardial subsidiary for approximately $2.3 million (EU €2 million). The Saint-Étienne, France-based subsidiary produces knitted and woven vascular grafts, valvulotomes and surgical glue, and reported approximately $3.3 million (EU €2.9 million) in sales over the past 12 months, Burlington, Mass.-based LeMaitre said. […]
LeMaitre Vascular (NSDQ:LMAT) this week ponied up $11 million in cash and another $3 million in post-closing payments for the vascular clot business at Applied Medical Resources Corp. The Burlington, Mass.-based company said the $14.2 million deal includes a one-year transition services provision that will see Applied Medical manufacture the devices for LeMaitre. The deal covers […]
Shares in LeMaitre Vascular (NSDQ:LMAT) have fallen slightly after the medical device maker missed sales expectations but met earnings per share consensus on Wall Street with its second quarter earnings results. The Burlington, Mass.-based company posted profits of $8.8 million, or 43¢ per share, on sales of $27 million for the three months ended June 30, […]
LeMaitre Vascular (NSDQ:LMAT) said yesterday that it agreed to deal its Reddick general surgery assets to Symmetry Surgical for more than $7 million. The deal includes Burlington, Mass.-based LeMaitre’s Reddick cholangiogram catheter and Reddick-Saye screw for laparoscopic cholecystectomies and a two-year manufacturing transition pact. LeMaitre said the gen-surg product line it’s selling put up revenues of $3.3 […]
LeMaitre Vascular (NSDQ:LMAT) said last week that it agreed to put up $14 million for tissue preservation service provider Restore Flow Allografts. The deal calls for Burlington, Mass.-based LeMaitre to pay $12 million up front and another $2 million in May 2018, plus earn-puts pegged to sales performance over the next 2 years. Fox River Grove, Ill.-based Restore […]
LeMaitre Vascular (NSDQ:LMAT) said last Friday it won clearance from China’s Food and Drug Administration for its Trivex transilluminated powered phlebectomy system. The Trivex system is designed to offer a minimally invasive option for removing varicose veins, the Burlington, Mass.-based company said. “We are pleased to receive this approval in the timeframe we expected. It […]
Venture capital firm New Enterprise Associates said today it picked up ex-Medtronic (NYSE:MDT) executive veep Dr. Stephen Oesterle as a venture partner for the firm. Prior to being an executive veep for the medical giant, Oesterle served as senior veep of medicine and technology, and served as a member of the executive committee for 14 years, […]
Dr. Margaret Hamburg, who resigned as FDA commissioner in February, was named foreign secretary of the U.S. Institute of Medicine this week.
Hamburg spent 6 years leading the federal safety watchdog, overseeing a massive revamp of its medical device, drug, food and tobacco regulation.